Genexine Competitors and Similar CompaniesClear all
Genexine's competitors and similar companies include JCR Pharmaceuticals, GBT (Global Blood Therapeutics) and Kamada Pharmaceuticals.
 Genexine Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. | |
Founding Date | Founding Date 1999 | Founding Date 1975 | Founding Date 2012 | Founding Date 1990 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Seongnam-si, KR HQ New York, US | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Rehovot, IL HQ Beit Kama, IL |
Employees | Employees 86 | Employees 934 | Employees 352106% increase | Employees 420 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 533.9 m | Valuation ($) 4.4 b | Valuation ($) 317 m |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩4.6b (FY, 2025) | Revenue (est.) ¥40.3b (FY, 2026) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $180.5m (FY, 2025) |
Cost of goods | Cost of goods (₩503.7m) (FY, 2025) | Cost of goods ¥7.6b (FY, 2026) | Cost of goods $3.3m (FY, 2021) | Cost of goods $72.1m (FY, 2025) |
Gross profit | Gross profit ₩7.8b (FY, 2025) | Gross profit ¥32.7b (FY, 2026) | Gross profit N/A | Gross profit $108.4m (FY, 2025) |
Net income | Net income (₩27.2b) (FY, 2025) | Net income ¥2.2b (FY, 2026) | Net income ($303.1m) (FY, 2021) | Net income $20.2m (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised $ 90m |
For sources of this data, please see the company profile
View Company Profiles
JCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyKamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View company